Skip to main content
Advertisement

AI Bias Analysis

4 models · Takes ~15 seconds

MedPage Today

One Drug Wins and Another Fails for Long COVID Fatigue

One Drug Wins and Another Fails for Long COVID Fatigue
ShareXFacebook

(MedPage Today) -- The antidepressant fluvoxamine delivered clinically relevant reductions in long COVID fatigue, but the diabetes drug metformin didn't outdo placebo, according to the randomized REVIVE-TOGETHER trial. Among 399 adults with long...

M

Source

MedPage Today

Read full article at MedPage Today

Opens original article in a new tab

Advertisement

Related Health Stories

Advertisement